Liu L - Search Results

1

APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer.

Chen S, Li X, Qin J, Chen Y, Liu L, Zhang D, Wang M, Wang M, Zhang D. Chen S, et al. Among authors: liu l. Int J Clin Exp Med. 2015 Jul 15;8(7):10548-57. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26379844 Free PMC article.

2

Biological characteristics and construction of stable ALDH-1 knock-down Hela cell lines.

Liu L, Yi J, Zhang D, Zhang D, Chen S, Li X, Qin J, Wang M, Wang M, Lin Z. Liu L, et al. Eur J Gynaecol Oncol. 2016;37(3):357-61. Eur J Gynaecol Oncol. 2016. PMID: 27352564

3

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer.

Yao T, Rao Q, Liu L, Zheng C, Xie Q, Liang J, Lin Z. Yao T, et al. Among authors: liu l. Virol J. 2013 Jun 3;10:175. doi: 10.1186/1743-422X-10-175. Virol J. 2013. PMID: 23732000 Free PMC article.

4

miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.

Liu L, Ning Y, Yi J, Yuan J, Fang W, Lin Z, Zeng Z. Liu L, et al. Biomed Pharmacother. 2020 May;125:109865. doi: 10.1016/j.biopha.2020.109865. Epub 2020 Feb 12. Biomed Pharmacother. 2020. PMID: 32058212 Free article.

5

Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer.

Liu L, Hu K, Zeng Z, Xu C, Lv J, Lin Z, Wen B. Liu L, et al. Recent Pat Anticancer Drug Discov. 2021;16(1):66-72. doi: 10.2174/1574892816666210211091543. Recent Pat Anticancer Drug Discov. 2021. PMID: 33573562

6

Low expression of KIF7 indicates poor prognosis in epithelial ovarian cancer.

Yao Y, Liu L, He W, Lin X, Zhang X, Lin Z, Zeng Z, Guo S. Yao Y, et al. Among authors: liu l. Cancer Biomark. 2019;26(4):481-489. doi: 10.3233/CBM-190328. Cancer Biomark. 2019. PMID: 31658044

7

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.

Deng Y, Liu L, Feng W, Lin Z, Ning Y, Luo X. Deng Y, et al. Among authors: liu l. Recent Pat Anticancer Drug Discov. 2021;16(4):533-539. doi: 10.2174/1574891X16666210706153740. Recent Pat Anticancer Drug Discov. 2021. PMID: 34551701

8

Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.

Liu L, Zeng Z, Yi J, Zuo L, Lv J, Yuan J, Lin Z, Luo R, Feng X. Liu L, et al. Cancer Biomark. 2019;24(2):213-221. doi: 10.3233/CBM-181849. Cancer Biomark. 2019. PMID: 30614797

9

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.

Liu L, Lv J, Lin Z, Ning Y, Li J, Liu P, Chen C. Liu L, et al. Among authors: liu p. Front Mol Biosci. 2022 Feb 9;8:785922. doi: 10.3389/fmolb.2021.785922. eCollection 2021. Front Mol Biosci. 2022. PMID: 35223984 Free PMC article.

10

MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance.

Liu L, Chen C, Liu P, Li J, Pang Z, Zhu J, Lin Z, Zhou H, Xie Y, Lan T, Chen ZS, Zeng Z, Fang W. Liu L, et al. Among authors: liu p. Adv Sci (Weinh). 2023 May;10(14):e2203423. doi: 10.1002/advs.202203423. Epub 2023 Mar 16. Adv Sci (Weinh). 2023. PMID: 36929633 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,118 results

Search Page

Filters